Logo-apb

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308 
pISSN: 2228-5881 

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by
Adv Pharm Bull. 2022;12(4): 757-762. doi: 10.34172/apb.2022.077
PMID: 36415644        PMCID: PMC9675927

Mini Review

Inorganic Nanoparticles: Toxic Effects, Mechanisms of Cytotoxicityand Phytochemical Interactions

Rashid Bhatti 1 * ORCID, Hadia Shakeel 1, Kausar Malik 1, Muhammad Qasim 2, Mohsin Ahmad Khan 3, Nadeem Ahmed 3, Shajia Jabeen 1

Cited by CrossRef: 3

1- Majeed B, Shwan D, Rashid K. A review on environmental contamination of petroleum hydrocarbons, its effects and remediation approaches. Environ Sci: Processes Impacts. 2025; [Crossref]
2- Sousa A, Carvalho F, Fernandes E, Freitas M. Quercetin protective potential against nanoparticle-induced adverse effects. Nanotoxicology. 2025;19(1):28 [Crossref]
3- Corsi F, Pelliccia A, Deidda Tarquini G, Urbani M, Failla C, Traversa E, Ghibelli L. Topical treatment of skin diseases with bioactive inorganic nanomaterials: Beyond drug delivery. Next Materials. 2025;6:100401 [Crossref]
4- Wang C, Huang C, Cao Y. Epigallocatechin gallate alleviated the in vivo toxicity of ZnO nanoparticles to mouse intestine. J of Applied Toxicology. 2024;44(5):686 [Crossref]
5- Vishwkarma H, Jain V, Darwhekar G. A comprehensive review on the classification, synthesis, characterization of nanopartices and their therapeutic impact. IJCAAP. 2024;9(3):183 [Crossref]
6- Singh A, Bhardwaj P, Upadhyay A, Pagani A, Upadhyay J, Bhadra J, Tisato V, Thakur M, Gemmati D, Mishra R, Zamboni P. Navigating regulatory challenges in molecularly tailored nanomedicine. Explor BioMat-X. 2024;1(2):124 [Crossref]
7- Hrubý M. Are stimuli-responsive hybrid copolymer nanoparticles the next innovation in tumor drug delivery?. Expert Opinion on Drug Delivery. 2025;22(1):11 [Crossref]